Analysis through immunohistochemistry on myocardial tissue revealed that the mVNS treatment was effective in reducing macrophage infiltration and lowering the levels of inflammatory factors (such as IL-1β and TNF-α) in the plasma post-myocardial infarction. The gene discussed is IL1B; the disease is myocardial infarction.